Navigation Links
Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins
Date:11/1/2011

BURLINGAME, Calif., Nov. 1, 2011 /PRNewswire/ -- Epitomics, Inc., a California based biotech company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for its Method for Identifying Differentially Expressed Proteins (application 10/705,109).  The Notice allowed 17 claims for detection of differentially expressed proteins in cell samples using libraries of antibodies.  This method has several potentially broad applications in the research and drug discovery markets, especially in the field of cancer.

"We are very excited to be granted the claims of this novel method," stated Dr. Guo-Liang Yu, Chief Executive Officer. "This is another step towards building a world class intellectual property estate around our unique and proprietary rabbit monoclonal  technology.  We look forward to continued success in the development of our technology and patents, and ultimately to providing the best antibodies and solutions to researchers and clinicians." 

About Epitomics

Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research and diagnostic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity, specificity and bioactivity both in vitro and in vivo. Epitomics, Inc. is headquartered in Burlingame, California, and operates wholly owned subsidiaries in Hong Kong and Hangzhou, the People's Republic of China. For more information about Epitomics, please visit www.epitomics.com


'/>"/>
SOURCE Epitomics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
2. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
3. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
4. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
5. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
8. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
9. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
10. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
11. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... Fiberstar, ... food and beverage industry launched a new innovative website. , After extensive research, ... the website offers global visitors updated ingredient usage tables by food application and ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... (AI)-powered technology for use in pathology research, today announced the results of ... from patients enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations ...
(Date:11/5/2019)... N.J. (PRWEB) , ... November ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... its next-generation cell line development technology, GPEx® Boost. The technology enhances Catalent’s ...
(Date:11/2/2019)... ... October 31, 2019 , ... A ... communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, ... is not informed of the latest data, potentially leading to patient risk. , ...
Breaking Biology Technology:
(Date:12/2/2019)... ... December 01, 2019 , ... ... tools, technologies, and techniques to hit the life-science landscape. For more than a ... speeding work in laboratories and facilitating biological discovery. This year’s crop of entries ...
(Date:11/22/2019)... ... November 21, 2019 , ... ... Park Comprehensive Cancer Center have announced a major step forward with that therapy, ... have announced that the company, spun off from Roswell Park in 2012, has ...
(Date:11/19/2019)... ... 2019 , ... Hosted at the Las Vegas Convention Center, and brought to ... largest gathering of MJBiz business professionals in the world. With over 1,300 exhibitors from ... is no show quite like it. Atlantic Ultraviolet will exhibit at Booth C9217, showcasing ...
Breaking Biology News(10 mins):